Central Diabetes Insipidus: Clinical Trials

8 trials for Central Diabetes Insipidus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 3 Not applicable, 2 Phase 4, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Not yet recruiting 1, Recruiting 1
Phase 42Completed 2
Phase 21Recruiting 1
Phase 31Completed 1

Follow Central Diabetes Insipidus: new trials by email Literature Review of Central Diabetes Insipidus trials Research Report on Central Diabetes Insipidus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls
Oxytocin nasal spray, Placebo - Arginine Vasopressin Deficiency, Central Diabetes Insipidus
Phase 2RecruitingUniversity Hospital, Basel, Switzerland422025-07-012025-10-03
Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children
Measure of Basal Copeptin level, Measure of arginine-stimulated copeptin, IRM - Primary Polydipsia, Central Diabetes Insipidus
Not applicableNot yet recruitingAssistance Publique Hopitaux De Marseille1552025-03-012025-02-13
Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls
MDMA, Placebo - Central Diabetes Insipidus
Not applicableRecruitingUniversity Hospital, Basel, Switzerland242025-01-272025-02-19
Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)
Melatonin - Oxytocin Deficiency, Hypopituitarism
Not applicableCompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau402022-04-012024-04-09
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Experimental: GLP1-RA (exenatide) administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau422021-09-132026-01-20
Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
Experimental: CRH administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus
Phase 4CompletedFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau522021-07-062024-04-03
Seoul National University Pituitary Disease Cohort Study
Dynamic hormone study and Magnetic resonance imaging - Pituitary Disease, Pituitary Incidentaloma
UnknownSeoul National University Hospital16002015-03-152020-03-18
A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
Desmopressin Oral Melt, Desmopressin intranasal - Central Diabetes Insipidus
Phase 3CompletedFerring Pharmaceuticals202011-01-012012-08-13

Narrower conditions

Diabetes Insipidus, Neurogenic (8)  ·  Hypopituitarism (3)  ·  Pituitary Diseases (3)  ·  Social Isolation (3)  ·  Combined Pituitary Hormone Deficiency (2)  ·  Hypothalamic Diseases (2)  ·  Mental Disorders (2)  ·  Acromegaly (1)  ·  Diabetes Insipidus (1)  ·  Diabetes Insipidus, Nephrogenic (1)  ·  Diabetes Mellitus (1)  ·  Pituitary ACTH Hypersecretion (1)  ·  Pituitary Neoplasms (1)  ·  Polydipsia, Psychogenic (1)  ·  Prolactinoma (1)

Broader conditions

Endocrine System Diseases (8)  ·  Female Urogenital Diseases (8)  ·  Female Urogenital Diseases and Pregnancy Complications (8)  ·  Kidney Diseases (8)  ·  Male Urogenital Diseases (8)  ·  Urogenital Diseases (8)  ·  Urologic Diseases (8)  ·  Diabetes Insipidus (7)  ·  Pituitary Diseases (5)  ·  Behavior (4)  ·  Brain Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Nervous System Diseases (4)  ·  Social Behavior (3)  ·  Hypothalamic Diseases (2)

Interventions

Deamino Arginine Vasopressin (1)  ·  Exenatide (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Melatonin (1)  ·  N-Methyl-3,4-methylenedioxyamphetamine (1)  ·  Organization and Administration (1)  ·  Oxytocin (1)  ·  Sodium Chloride (1)

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (3)  ·  University Hospital, Basel, Switzerland (2)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Ferring Pharmaceuticals (1)  ·  Seoul National University Hospital (1)

Countries

Spain (3)  ·  Switzerland (2)  ·  France (1)  ·  Japan (1)  ·  South Korea (1)

Top investigators

Anna Aulinas, MD PhD (2)  ·  Jung Hee Kim, M.D (1)  ·  Mirjam Christ-Crain, Prof. (1)  ·  Mirjam Christ-Crain, Prof. MD (1)

Results publications

PMID 23811987, PMID 39824923